Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has announced the proposed issuance of 1.5 million options expiring in December 2027, priced at $0.09 each. This strategic move could attract investor interest and potentially enhance liquidity in the market. Investors keen on opportunities in the pharmaceutical sector may find this development noteworthy.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.